148 related articles for article (PubMed ID: 31191048)
1. Contraception with estradiol valerate and dienogest: adherence to the method.
Fruzzetti F; Paoletti AM; Fidecicchi T; Posar G; Giannini R; Gambacciani M
Open Access J Contracept; 2019; 10():1-6. PubMed ID: 31191048
[No Abstract] [Full Text] [Related]
2. Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study.
Briggs P; Serrani M; Vogtländer K; Parke S
Int J Womens Health; 2016; 8():477-487. PubMed ID: 27695365
[TBL] [Abstract][Full Text] [Related]
3. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
[TBL] [Abstract][Full Text] [Related]
4. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
5. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
6. Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill.
Guida M; Bifulco G; Di Spiezio Sardo A; Scala M; Fernandez LM; Nappi C
Int J Womens Health; 2010 Aug; 2():279-90. PubMed ID: 21151673
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
Palacios S; Wildt L; Parke S; Machlitt A; Römer T; Bitzer J
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):57-62. PubMed ID: 19969409
[TBL] [Abstract][Full Text] [Related]
8. Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest.
Rafie S; Borgelt L; Koepf ER; Temple-Cooper ME; Lehman KJ
Int J Womens Health; 2013; 5():313-21. PubMed ID: 23788843
[TBL] [Abstract][Full Text] [Related]
9. Estradiol valerate/dienogest: a novel combined oral contraceptive.
Borgelt LM; Martell CW
Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
[TBL] [Abstract][Full Text] [Related]
10. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
11. Estradiol valerate and dienogest: a new approach to oral contraception.
Kiley JW; Shulman LP
Int J Womens Health; 2011; 3():281-6. PubMed ID: 21892339
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
Jensen JT
Expert Opin Pharmacother; 2010 May; 11(7):1147-57. PubMed ID: 20367275
[TBL] [Abstract][Full Text] [Related]
13. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
14. Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction.
Graziottin A
Minerva Ginecol; 2014 Oct; 66(5):479-95. PubMed ID: 25245997
[TBL] [Abstract][Full Text] [Related]
15. [Association of E2v/DNG as contraceptive choice for a better quality of life of women].
Nappi RE
Minerva Ginecol; 2012 Feb; 64(1):41-52. PubMed ID: 22334230
[TBL] [Abstract][Full Text] [Related]
16. Estradiol valerate/dienogest: a novel oral contraceptive.
Whalen KL; Rose R
Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
[TBL] [Abstract][Full Text] [Related]
17. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
18. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
De Leo V; Fruzzetti F; Musacchio MC; Scolaro V; Di Sabatino A; Morgante G
Contraception; 2013 Sep; 88(3):364-8. PubMed ID: 23769016
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North America.
Nelson A; Parke S; Mellinger U; Zampaglione E; Schmidt A
J Womens Health (Larchmt); 2014 Mar; 23(3):204-10. PubMed ID: 24279594
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
von Schoultz B
Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
